1,916
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Cinnoline derivatives as human neutrophil elastase inhibitors

, , , , , , , & show all
Pages 628-639 | Received 11 Mar 2015, Accepted 06 May 2015, Published online: 21 Jul 2015

Figures & data

Figure 1. Structures of selected HNE inhibitors.

Figure 1. Structures of selected HNE inhibitors.

Scheme 1. Synthesis of cinnoline derivatives 4–8.

Scheme 1. Synthesis of cinnoline derivatives 4–8.

Scheme 2. Synthesis of cinnoline derivatives 11a–d.

Scheme 2. Synthesis of cinnoline derivatives 11a–d.

Scheme 3. Synthesis of cinnoline derivatives 16a–c, 17a–c, and 19.

Scheme 3. Synthesis of cinnoline derivatives 16a–c, 17a–c, and 19.

Scheme 4. Synthesis of cinnoline derivatives 21a–d, 22. and 24.

Scheme 4. Synthesis of cinnoline derivatives 21a–d, 22. and 24.

Table 1. HNE inhibitory activity of cinnolone derivatives 4–8, 11a–d, 16a–c, and 18a–g.

Table 2. HNE Inhibitory activity of cinnolone derivatives 21a–d and 24.

Table 3. HNE inhibitory activity of cinnoline derivatives 17a–c, 22, and 19.

Figure 2. Kinetics of HNE inhibition by cinnoline derivative 18a. Representative double-reciprocal Lineweaver–Burk plot of substrate hydrolysis by HNE in the absence and presence of the compounds 18a is shown. The representative plot is from three independent experiments.

Figure 2. Kinetics of HNE inhibition by cinnoline derivative 18a. Representative double-reciprocal Lineweaver–Burk plot of substrate hydrolysis by HNE in the absence and presence of the compounds 18a is shown. The representative plot is from three independent experiments.

Table 4. Half-life (t1/2) for the spontaneous hydrolysis of selected cinnolinone derivatives.

Figure 3. Superimposed docking poses of peptide chloromethyl ketone and novel small-molecule HNE inhibitors. Co-crystallized peptide chloromethyl ketone inhibitor is shown in yellow. Residues within 5 Å of this ligand are visible. Panel (A) Docking poses of reference compound 5bCitation28 (dark-green) and compound 18a (blue). Panel (B) Docking poses of compounds 16b (violet) and 17b (brown).

Figure 3. Superimposed docking poses of peptide chloromethyl ketone and novel small-molecule HNE inhibitors. Co-crystallized peptide chloromethyl ketone inhibitor is shown in yellow. Residues within 5 Å of this ligand are visible. Panel (A) Docking poses of reference compound 5bCitation28 (dark-green) and compound 18a (blue). Panel (B) Docking poses of compounds 16b (violet) and 17b (brown).

Figure 4. Hypothetical model for the nucleophilic attack of Ser195 at the carbonyl group of cinnoline derivative (18a) accompanied by synchronous proton transfer from Ser195 to Asp102 via the catalytic triad. The key angle α is indicated (see text for details). The model is based on the proposed mechanism of synchronous proton transfer from the oxyanion hole in serine proteasesCitation40,Citation47.

Figure 4. Hypothetical model for the nucleophilic attack of Ser195 at the carbonyl group of cinnoline derivative (18a) accompanied by synchronous proton transfer from Ser195 to Asp102 via the catalytic triad. The key angle α is indicated (see text for details). The model is based on the proposed mechanism of synchronous proton transfer from the oxyanion hole in serine proteasesCitation40,Citation47.

Table 5. Geometric parameters of the enzyme–inhibitor complexes predicted by molecular docking.

Supplemental material

IENZ_1057718_Supp.pdf

Download PDF (403.9 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.